Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies - Concepedia

Concepedia

Publication | Open Access

Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies

DOI Full Paper Access

37

Citations

12

References

2023

Year

Walter Reinisch, Wayne J.G. Hellstrom, Radboud J. E. M. Dolhain, Suresh C. Sikka, René Westhovens, Rajiv Mehta, Timothy E. Ritter, Ursula Seidler, Oleksandr Golovchenko, Olena Garmish,

Annals of the Rheumatic Diseases

Abstract

Results suggest that once daily filgotinib 200 mg for 13 weeks has no measurable impact on semen parameters or sex hormones in men with active IBD or inflammatory rheumatic diseases.

References

	Year	Citations

Page 1